Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 29;17(9):1514.
doi: 10.3390/nu17091514.

NSAIDs, Ileal Inflammation, and Glucose Metabolism: Insights from a Large Retrospective Cohort

Stephanie Hosanna Rodriguez  1 , Gilles Jadd Hoilat  1   2 , Nikash Pradhan  3 , Carolina Gonzalez Bravo  3 , Marcelo L G Correia  1   4 , Mohamad Mokadem  1   2   5
Affiliations

NSAIDs, Ileal Inflammation, and Glucose Metabolism: Insights from a Large Retrospective Cohort

Stephanie Hosanna Rodriguez et al. Nutrients. .

Abstract

Background/objectives: Ileitis, or inflammation of the terminal ileum, is often linked to inflammatory bowel disease (IBD), especially Crohn's disease, but may also arise from non-steroidal anti-inflammatory drug (NSAID) use. While NSAIDs are known to cause gastrointestinal injury, their role in ileitis and downstream metabolic consequences remains unclear. This study evaluated the relationship between NSAID use, biopsy-confirmed ileitis, and glucose metabolism abnormalities in patients with and without IBD.

Methods: We conducted a retrospective cohort study of 3725 adults who underwent ileal biopsy between 2009 and 2022 at a tertiary care center. Patients were stratified based on histologic evidence of ileitis. Collected data included demographics, IBD status, NSAID and steroid use, hemoglobin A1C, fasting glucose, and diagnoses of abnormal glucose metabolism. Multivariable logistic and linear regression models adjusted for age, BMI, sex, steroid use, and IBD.

Results: Of 3725 patients, 876 had biopsy-confirmed ileitis. NSAID use-categorized as current, historical, or inpatient-was not significantly associated with ileitis after adjustment. In contrast, IBD was the strongest independent predictor (p < 0.05). Although unadjusted analyses showed lower A1C in the ileitis group (p = 0.003), this was not significant after controlling for confounders (p = 0.084). No significant associations were found between ileitis and fasting glucose or abnormal glucose metabolism. Age and BMI were the dominant predictors of glycemic abnormalities.

Conclusions: NSAID use was not associated with biopsy-confirmed ileitis or impaired glucose metabolism. Traditional metabolic risk factors were stronger predictors of glycemic abnormalities than localized ileal inflammation.

Keywords: ileitis; inflammatory bowel disease (IBD); non-steroidal anti-inflammatory drugs (NSAIDs); type 2 diabetes mellitus (T2DM).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. DiLauro S., Crum-Cianflone N.F. Ileitis: When It Is Not Crohn’s Disease. Curr. Gastroenterol. Rep. 2010;12:249–258. doi: 10.1007/s11894-010-0112-5. - DOI - PMC - PubMed
    1. Pais T.P., Fernandes S., Fernandes C., Ribeiro I., Carvalho J. Terminal ileitis found upon imaging: Is it always Crohn’s disease? Am. J. Gastroenterol. 2014;109:1089. doi: 10.1038/ajg.2014.114. - DOI - PubMed
    1. Park S.C., Chun H.J., Kang C.D., Sul D. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J. Gastroenterol. 2011;17:4647–4653. doi: 10.3748/wjg.v17.i42.4647. - DOI - PMC - PubMed
    1. Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., Russell R.I. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1992;327:749–754. doi: 10.1056/NEJM199209103271101. - DOI - PubMed
    1. Ghlichloo I., Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) StatPearls Publishing; Treasure Island, FL, USA: 2024. - PubMed

LinkOut - more resources